Silexion Therapeutics Corp
SLXN· Nasdaq
SLXNSilexion Therapeutics Corp
Filed Mar 17, 2026 · 10-K · 76 days after period end · 0001178913-26-000953
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures |
|---|---|---|
| Net Income | -$4.41M | -$1.75M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Silexion Therapeutics Corp · CIK 2022416 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 17, 2026 · 76 d after period end
